6_B?0#B&J*S}ECU#,E:~7KB,@0R!*GW(X!-5
SYSTEM PROCESSING...
6_B?0#B&J*S}ECU#,E:~7KB,@0R!*GW(X!-5
SYSTEM PROCESSING...
Posted: 2025-04-16 23:08:39 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-16 23:08:57 UTC
Verified By
Rollup News
The DapaTAVI trial investigates the use of the SGLT2 inhibitor dapagliflozin in patients undergoing transcatheter aortic-valve implantation, a group often excluded from previous trials.
SGLT2 inhibitors
dapagliflozin
transcatheter aortic-valve implantation (TAVI)
DapaTAVI trial
Exclusion of TAVI patients from SGLT2 inhibitor trials